Beta-Lactam Antibiotics — MCQs
The molecular basis of penicillin resistance in *S. pneumoniae* is:
Third-generation cephalosporins include all of the following except:
Which one of the following penicillin group drugs is penicillinase resistant?
The most common genetic element responsible for drug resistance in staphylococci is:
Which of the following statements about cephalosporins is false?
Which of the following microorganisms will be resistant to meropenem and aminoglycosides but sensitive to piperacillin tazobactam and cotrimoxazole?
Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :
Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT
Which specific beta-lactamase inhibitor is commonly used to enhance the efficacy of beta-lactam antibiotics in the treatment of bacterial endocarditis?
Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?
Beta-Lactam Antibiotics Indian Medical PG Practice Questions and MCQs
Question 1: The molecular basis of penicillin resistance in *S. pneumoniae* is:
- A. Alteration in cell membranes
- B. Alteration in the cell wall
- C. Alteration of penicillin-binding protein (Correct Answer)
- D. Production of beta-lactamase enzyme
Explanation: ***Alteration of penicillin-binding protein*** - The primary mechanism of **penicillin resistance in *Streptococcus pneumoniae*** involves modifications to its **penicillin-binding proteins (PBPs)**, which are the targets of penicillin. - These alterations reduce the affinity of PBPs for penicillin, allowing cell wall synthesis to continue even in the presence of the antibiotic. *Alteration in cell membranes* - Changes in cell membranes are not the primary mechanism of **penicillin resistance** in bacteria. - **Penicillins** primarily target the **bacterial cell wall**, not the cell membrane. *Alteration in the cell wall* - While penicillin resistance *involves* the cell wall, the direct "alteration in the cell wall" itself is not the molecular basis. - The key is the change in the **PBPs** located within or associated with the cell wall, not a general change in the cell wall structure. *Production of beta-lactamase enzyme* - **Beta-lactamase production** is a common mechanism of penicillin resistance in many bacteria (e.g., *Staphylococcus aureus*, *Haemophilus influenzae*), but it is **not the primary mechanism for penicillin resistance in *Streptococcus pneumoniae***. - *S. pneumoniae* primarily relies on **altered PBPs** to evade penicillin, rather than enzymatic degradation of the antibiotic.
Question 2: Third-generation cephalosporins include all of the following except:
- A. Cefoperazone
- B. Cefixime
- C. Ceftizoxime
- D. Cefoxitin (Correct Answer)
Explanation: ***Cefoxitin*** - **Cefoxitin** is a **second-generation cephalosporin**, primarily known for its activity against **anaerobic bacteria** (like *Bacteroides fragilis*) and certain **Gram-negative bacteria**. - Its spectrum of activity and chemical structure classify it distinctly from third-generation cephalosporins, which offer broader Gram-negative coverage and better penetration into the CNS. *Ceftizoxime* - **Ceftizoxime** is a **third-generation cephalosporin** with a broad spectrum of activity against many **Gram-negative bacilli** and some **Gram-positive cocci**. - It is often used for serious infections, including intra-abdominal and lower respiratory tract infections. *Cefoperazone* - **Cefoperazone** is another **third-generation cephalosporin** known for its activity against ***Pseudomonas aeruginosa***, a common feature of many third-generation agents. - It also provides good activity against other Gram-negative organisms, making it suitable for a range of severe infections. *Cefixime* - **Cefixime** is an **oral third-generation cephalosporin** commonly used for outpatient treatment of infections such as **otitis media**, **streptococcal pharyngitis**, and **uncomplicated urinary tract infections**. - Its oral bioavailability distinguishes it from many injectable third-generation cephalosporins but it shares the typical third-generation spectrum of activity.
Question 3: Which one of the following penicillin group drugs is penicillinase resistant?
- A. Amoxicillin
- B. Cloxacillin (Correct Answer)
- C. Penicillin G
- D. Piperacillin
Explanation: ***Cloxacillin*** - **Cloxacillin** is a narrow-spectrum beta-lactam antibiotic of the penicillin class that is **penicillinase-resistant**. - It is often used to treat infections caused by penicillinase-producing **staphylococci**. *Amoxicillin* - **Amoxicillin** is an **aminopenicillin** that is **not penicillinase-resistant** and is often combined with a **beta-lactamase inhibitor** like **clavulanic acid** to enhance its spectrum of activity. - It is a **broad-spectrum antibiotic** effective against a wide range of gram-positive and gram-negative bacteria. *Penicillin G* - **Penicillin G** is a **natural penicillin** and is **susceptible to penicillinase (beta-lactamase)** enzymes, which break down its beta-lactam ring. - It has a narrow spectrum of activity, primarily against **gram-positive cocci** and **some gram-negative cocci**. *Piperacillin* - **Piperacillin** is a **ureidopenicillin**, a **broad-spectrum** penicillin that is **not penicillinase-resistant** when used alone. - It is usually combined with a **beta-lactamase inhibitor** like **tazobactam** to protect it from degradation and expand its coverage, especially against **Pseudomonas aeruginosa.**
Question 4: The most common genetic element responsible for drug resistance in staphylococci is:
- A. Plasmids (Correct Answer)
- B. Transduction
- C. Conjugation
- D. Translation
Explanation: ***Plasmids*** - **Plasmids** are extrachromosomal DNA molecules that carry genes for antibiotic resistance, including **β-lactamase genes** and the **mecA gene** (responsible for methicillin resistance in MRSA). - Plasmids are the **primary genetic vehicles** for resistance in staphylococci and can be transferred between bacteria through various mechanisms (transduction, conjugation, transformation). - They enable rapid dissemination of **multi-drug resistance** patterns in staphylococcal populations. *Transduction* - **Transduction** is a horizontal gene transfer **mechanism** via bacteriophages, not a genetic element itself. - While transduction is actually the **most common transfer mechanism** in staphylococci (especially for plasmid and chromosomal DNA transfer), it is the **process** of transfer, not the genetic element carrying resistance genes. - The question asks about the genetic element, not the transfer mechanism. *Conjugation* - **Conjugation** is another horizontal gene transfer **mechanism** involving direct cell-to-cell contact, not a genetic element. - Conjugation is **relatively rare** in staphylococci compared to Gram-negative bacteria, though it can occur with certain plasmids. - Like transduction, this is a transfer process, not the genetic vehicle itself. *Translation* - **Translation** is the cellular process of protein synthesis from mRNA by ribosomes, completely unrelated to resistance gene acquisition. - While translation produces resistance proteins (like β-lactamase enzymes), it does not represent the genetic element that carries or transfers resistance genes.
Question 5: Which of the following statements about cephalosporins is false?
- A. Cefoperazone has got antipseudomonal effect.
- B. Cephalosporins act by inhibiting cell wall synthesis.
- C. Ceftazidime is a 3rd generation cephalosporin.
- D. Cefoxitin has no activity against anaerobes. (Correct Answer)
Explanation: ***Cefoxitin has no activity against anaerobes.*** - This statement is **false** because **cefoxitin** is a second-generation cephalosporin known for its **excellent activity against anaerobic bacteria**, particularly *Bacteroides fragilis*. - Its anaerobic coverage makes it useful for treating infections where these organisms are suspected, such as intra-abdominal and pelvic infections. *Ceftazidime is a 3rd generation cephalosporin.* - This statement is **true**. **Ceftazidime** is a third-generation cephalosporin characterized by its broad-spectrum activity, including significant coverage against **Pseudomonas aeruginosa**. - Its primary clinical utility is often in treating difficult Gram-negative infections. *Cefoperazone has got antipseudomonal effect.* - This statement is **true**. **Cefoperazone** is a third-generation cephalosporin that exhibits **antipseudomonal activity**, similar to ceftazidime. - It is often used for treating infections caused by **Pseudomonas aeruginosa** and other difficult Gram-negative bacteria. *Cephalosporins act by inhibiting cell wall synthesis.* - This statement is **true**. Like other beta-lactam antibiotics, **cephalosporins** exert their bactericidal effect by **inhibiting bacterial cell wall synthesis**. - They bind to and inactivate **penicillin-binding proteins (PBPs)**, which are essential enzymes involved in peptidoglycan cross-linking, leading to compromised cell wall integrity and bacterial lysis.
Question 6: Which of the following microorganisms will be resistant to meropenem and aminoglycosides but sensitive to piperacillin tazobactam and cotrimoxazole?
- A. Pseudomonas
- B. Acinetobacter
- C. Burkholderia cepacia
- D. Stenotrophomonas (Correct Answer)
Explanation: ***Stenotrophomonas maltophilia*** - *Stenotrophomonas maltophilia* exhibits **intrinsic resistance to carbapenems (like meropenem)** due to the presence of L1 and L2 metallo-beta-lactamases and chromosomally encoded beta-lactamases. - It is **resistant to aminoglycosides** via aminoglycoside-modifying enzymes and efflux pump mechanisms. - **Trimethoprim-sulfamethoxazole (cotrimoxazole) is the drug of choice** with consistent susceptibility, making it the first-line treatment. - **Susceptibility to piperacillin-tazobactam is variable** - while some isolates may show in vitro susceptibility, clinical efficacy is inconsistent and it is not considered a reliable first-line agent. Among the options given, this organism best fits the described pattern. *Pseudomonas aeruginosa* - **Generally susceptible to carbapenems (meropenem) and aminoglycosides**, which are important therapeutic options. - Does not match the resistance pattern described in the question. *Acinetobacter baumannii* - Shows **multidrug resistance including carbapenems and aminoglycosides** in most clinical isolates. - However, typically also **resistant to piperacillin-tazobactam and cotrimoxazole**, making it inconsistent with the described susceptibility pattern. *Burkholderia cepacia complex* - Exhibits **intrinsic resistance to multiple antibiotics** including aminoglycosides and often carbapenems. - **Variable and often resistant to piperacillin-tazobactam**, and susceptibility to cotrimoxazole is inconsistent. - Does not reliably match the described antibiotic profile.
Question 7: Extended-spectrum beta-lactamases (ESBLs) are characterized by activity against all except :
- A. Carbapenems (Correct Answer)
- B. Oxyimino-cephalosporins
- C. Penicillins
- D. Cephalosporins
Explanation: ***Carbapenems*** - **Extended-spectrum beta-lactamases (ESBLs)** typically do not hydrolyze **carbapenems**, making these antibiotics generally effective against most ESBL-producing bacteria. - The retention of activity against carbapenems is a key distinction between ESBLs and other beta-lactamases like **carbapenemases**. *Oxyimino-cephalosporins* - ESBLs are specifically named for their ability to hydrolyze and inactivate **oxyimino-cephalosporins**, such as **cefotaxime**, **ceftriaxone**, and **ceftazidime**. - This hydrolysis makes these vital third-generation cephalosporins ineffective for treating infections caused by ESBL-producing organisms. *Penicillins* - ESBLs can effectively hydrolyze and render many **penicillins** inactive, especially those lacking beta-lactamase inhibitors. - This broadens the resistance spectrum beyond just cephalosporins to include common penicillins. *Cephalosporins* - ESBLs primarily confer resistance to a wide range of **cephalosporins**, particularly the **first-, second-, and third-generation agents**. - This resistance is a major clinical challenge, necessitating the use of alternative antibiotic classes.
Question 8: Production of inactivating enzymes is an important mechanism of drug resistance for all of these antibiotics EXCEPT
- A. Quinolone (Correct Answer)
- B. Penicillin
- C. Chloramphenicol
- D. Aminoglycoside
Explanation: ***Quinolone*** - The primary mechanisms of resistance to **quinolones** involve mutations in the **gyrase** and **topoisomerase IV** enzymes or efflux pump overexpression, rather than enzymatic inactivation of the drug itself. - Unlike other antibiotic classes listed, quinolones are not typically susceptible to bacterial enzymes that degrade or modify their structure. *Penicillin* - **Penicillins** are highly susceptible to inactivation by **beta-lactamase enzymes**, which hydrolyze the beta-lactam ring, rendering the antibiotic ineffective. - This enzymatic degradation is a major mechanism of resistance developed by many bacterial species to penicillin and other beta-lactam antibiotics. *Chloramphenicol* - Resistance to **chloramphenicol** is primarily mediated by the enzyme **chloramphenicol acetyltransferase (CAT)**, which acetylates the drug, preventing its binding to the bacterial ribosome. - This enzymatic modification is a classic example of drug inactivation leading to resistance. *Aminoglycoside* - **Aminoglycosides** are frequently inactivated by a variety of **aminoglycoside-modifying enzymes (AMEs)**, such as acetyltransferases, phosphoryltransferases, and nucleotidyltransferases. - These enzymes add chemical moieties to the aminoglycoside molecule, preventing its binding to the bacterial ribosome and inhibiting protein synthesis.
Question 9: Which specific beta-lactamase inhibitor is commonly used to enhance the efficacy of beta-lactam antibiotics in the treatment of bacterial endocarditis?
- A. Clavulanic acid
- B. Sulbactam
- C. Tazobactam (Correct Answer)
- D. Avibactam
Explanation: ***Tazobactam*** - **Tazobactam** is a widely used **beta-lactamase inhibitor** that, when combined with **piperacillin (piperacillin/tazobactam)**, provides **broad-spectrum coverage** against beta-lactamase-producing bacteria [2]. - In the context of **bacterial endocarditis**, particularly for **empirical therapy** when the causative organism is unknown, **piperacillin/tazobactam** offers excellent coverage for Gram-positive cocci (including some staphylococci), Gram-negative bacteria, and anaerobes. - This combination is frequently used in **prosthetic valve endocarditis** or when multidrug-resistant organisms are suspected, making tazobactam a valuable choice for enhancing beta-lactam efficacy in serious endocardial infections. *Clavulanic acid* - **Clavulanic acid** is a beta-lactamase inhibitor typically combined with **amoxicillin** (amoxicillin/clavulanic acid) or **ticarcillin** (ticarcillin/clavulanic acid) [1]. - While effective for many infections, the amoxicillin combination is primarily available in oral formulation and has a **narrower spectrum** compared to piperacillin/tazobactam. - It is generally not preferred for severe infections like bacterial endocarditis requiring parenteral therapy and broad coverage. *Sulbactam* - **Sulbactam** is a beta-lactamase inhibitor commonly paired with **ampicillin** (ampicillin/sulbactam) [1]. - The **ampicillin/sulbactam combination** is actually used in endocarditis, particularly for **Enterococcus species** infections. - However, for **broad empirical coverage** in endocarditis (covering resistant Gram-negatives and anaerobes), piperacillin/tazobactam is more commonly selected. *Avibactam* - **Avibactam** is a newer beta-lactamase inhibitor combined with **ceftazidime** (ceftazidime/avibactam) or **ceftaroline**. - It is particularly effective against **carbapenem-resistant Enterobacteriaceae** and certain **multidrug-resistant organisms**. - While valuable in resistant infections, it is not a first-line or commonly used choice for typical bacterial endocarditis compared to piperacillin/tazobactam.
Question 10: Why does Mycoplasma genitalium show a higher rate of antimicrobial resistance compared to other STI pathogens?
- A. Due to plasmid exchange with other bacteria
- B. Due to absence of cell wall making beta-lactams ineffective
- C. Due to biofilm formation protecting from antibiotics
- D. Due to rapid mutation in the 23S rRNA gene (Correct Answer)
Explanation: ***Due to rapid mutation in the 23S rRNA gene*** [1] - *Mycoplasma genitalium* develops **resistance to macrolides**, a primary treatment, through **point mutations in the 23S rRNA gene** [1]. - These mutations alter the ribosomal binding site, preventing macrolide antibiotics from inhibiting **bacterial protein synthesis** [2]. *Due to plasmid exchange with other bacteria* - *Mycoplasma genitalium* **lacks a cell wall** and generally does not engage in significant plasmid exchange, which is a common mechanism for horizontal gene transfer and resistance acquisition in many other bacteria. - While other bacteria acquire resistance through plasmids, this mechanism is **not prominent** in *Mycoplasma genitalium*. *Due to absence of cell wall making beta-lactams ineffective* - The **absence of a cell wall** inherently makes beta-lactam antibiotics ineffective against *Mycoplasma genitalium*, as **beta-lactams target cell wall synthesis**. - However, this is a **natural resistance** and does not explain its higher rate of acquired antimicrobial resistance to other classes of antibiotics, such as macrolides. *Due to biofilm formation protecting from antibiotics* - While **biofilm formation can protect bacteria** from antibiotics, it is not the primary or most notable mechanism explaining the high rate of acquired resistance in *Mycoplasma genitalium*. - The major concern for *M. genitalium* resistance lies in **specific genetic mutations** affecting relevant antibiotic targets.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free